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Background: Atrial fibrillation (AF) patients are prescribed oral-anticoagulant (OAC) 
therapy, often warfarin, to reduce stroke risk.  However, it is under-prescribed and 
sometimes refused by patients. We explored existing qualitative evidence about 
patients’ and health professionals’ experiences of OAC therapy. 
Method: Systematic searches of eight bibliographic databases were conducted. Quality 
was appraised using CASP and data from ten studies were synthesised qualitatively. 
Findings: Four third-order constructs emerged: (1) Diagnosing AF and the 
communication of information, (2) Deciding on OAC therapy, (3) Challenges revolving 
around patient issues, and (4) Healthcare challenges. Synthesis uncovered perspectives 
that could not be achieved through individual studies. 
Discussion: Physicians’ and patients’ experiences present a dichotomy of opinion on 
decision making, which requires further exploration and changes in practice. Outcomes 
of workload pressure on both health professionals and patients should be investigated. 
The need for ongoing support and education to patients and physicians is critical to 
achieve best practice and treatment adherence.  
Practice Implications: Such research could encourage health professionals to 
understand and attend better to the needs and concerns of the patient. 
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Patients’ and health professionals’ views and experiences of atrial 
fibrillation and oral-anticoagulant therapy: a meta-synthesis 
1. Introduction 
Atrial Fibrillation (AF) is the most common arrhythmia in clinical practice and is 
associated with increased morbidity and mortality. [1, 2] AF is an independent risk 
factor for stroke conferring a risk five times that of matched controls. [3] Hence, stroke 
risk reduction with antithrombotic therapy is a crucial component of AF management. 
[2, 4] Guidelines recommend life-long oral-anticoagulation therapy (OAC) for patients 
with one or more risk factors for stroke. [2] However, such therapy remains 
underutilised. [5, 6]  
 
There are a number of complex factors which make prescription, and adherence, of 
OAC challenging. Physicians may display uncertainty about balancing the risk of stroke 
and the risk of bleeding, which may be passed onto patients. [7] Two recent systematic 
reviews emphasised the impact of physicians’ apprehension about feeling responsible 
for a major bleed which seemed to outweigh their concern about risk of stroke. [8, 9] 
This may be related to the Hippocratic Oath to ‘first do no harm’ [10]: responsibility is 
attributed to harm perceived to be caused by ‘acts of commission’, i.e. prescribing 
OAC, which are not felt with ‘acts of omission’, i.e., increasing the risk of stroke by 
not prescribing OAC.  
 
Very little is known about patients’ understanding of AF and OAC treatment. What we 
do know is that patients with AF report poorer quality of life compared to the general 
population [4, 11], and greater levels of anxiety. [12]  
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This review of the literature indicated a need to consolidate existing evidence about 
patients’ and physicians’ experience of AF and OAC. The complexity inherent in this 
field make the need for patient-centred care, effective communication skills, and 
individually-tailored education, as recommended by NICE [1], particularly significant. 
To determine what is already known, implications for practice and to indicate where 
further research should be focused we conducted a meta-synthesis of qualitative 
evidence examining patients’ and health professionals’ experiences and beliefs about 
AF and OAC therapy. 
 
2. Method 
Meta-synthesis of qualitative evidence is modelled on traditional systematic review 
methodology [13] and this meta-synthesis follows the techniques described in Taylor 
et al. [14] A systematic search strategy, screening and quality appraisal were employed. 
Search terms were developed from two main bibliographic database categories: ‘atrial 
fibrillation’ and ‘anticoagulant therapy’; a qualitative methodology filter was used to 
ensure the retrieval of qualitative studies [15] (see Appendix A for the full search 
strategy). Web of Knowledge, Ingenta connect, ScienceDirect (EBSCO), Swetswise, 
Sage Journals online, PsycInfo and the Cochrane Library were searched to include 
publications up to 26th August 2011. The UK electronic theses online service (EThOS) 
and Google scholar were searched to identify UK dissertations and grey literature. 
 
Studies retrieved were screened using the following inclusion criteria: studies that 
explored views or experiences of patients or carers and/or health professionals (e.g. 
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physicians and/or nurses and/or pharmacists) about AF and/or OAC using qualitative 
methods (defined as using qualitative techniques for recruitment strategies, data 
collection, and data analysis). Once screened, duplicates were removed and reference 
checking and citation searches were conducted. Some authors were contacted directly 
if data or methodological information were missing. 
 
The quality of studies was appraised using the Critical Appraisal Skills Programme 
(CASP) Tool for qualitative research [16], independently by the research team (CBX, 
RS, DAL), who then met to agree the quality rating. Papers deemed to be of low quality 
were not excluded but their findings were given less “weight” during the synthesis 
process [17].   
 
Synthesis proceeded following the principles outlined by Malpass et al. [18].  Articles 
were read in-depth and their findings recorded in data extraction forms. Key themes 
and categories were identified (first-order constructs) and grouped through descriptive 
coding to form second order constructs (See Table 2). The synthesis then involved the 
interpretative activity of translating studies into each other, i.e. comparing and 
contrasting themes across papers to identify super-ordinate themes, or third-order 
constructs, which represent the collective meanings of findings from individual papers 
to enable a theoretical interpretation of the phenomenon. This was facilitated by the use 
of mind maps to think through interrelations between first- and second-order constructs 
within and between papers to ensure the development of third-order constructs 
remained true to the data throughout the synthesis (See Figure 1 and Table 2). 
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The topic-based search terms yielded over 100,000 references but with the qualitative 
methodology filter this number was reduced to 12 unique studies (see Figure 2). Two 
studies were excluded: one explored experiences of patients with an implantable atrial 
defibrillator; another was a method-based paper about using qualitative research to 
discontinue one arm of a trial.  Ten studies met the inclusion criteria and were included 
in this meta-synthesis (see Table 3 for summary of characteristics). The four third-order 
constructs identified are presented in series (see Table 2).  
 
3.1 Diagnosing AF and the communication of information 
Only McCabe et al. [19] explored patients’ pre-diagnosis experiences. They found that 
some were diagnosed accurately and quickly, whilst for others the process was slow 
because arrhythmia is difficult to document on an ECG and AF symptoms are not 
always clear which led to some patients being misdiagnosed with stress. Murray et al 
[20] was also found a lack of agreement on the severity of AF and physicians expressed 
a lack in confidence in detecting paroxysmal AF (i.e. self-terminating episodes of AF 
typically lasting <48 hours but no longer than 7 days) due to its intermittent nature. 
Nevertheless, once AF was diagnosed, patients reported a sense of relief despite this 
sometimes being shocking news. [19]   
 
“The doctor came in and said: “The good news is you’re not crazy. The bad 
news is there is something wrong.” I’m like - I told you - you should have 
believed me in the first place. It was almost a relief - not that something was 
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wrong with my heart, but that at least I know something’s wrong. It may be 
fixed versus going on feeling yucky and not getting an answer.” (Patient) 
[19] 
 
Participants from three studies [19, 21, 22] found that additional information on 
possible treatments to control AF symptoms and OAC was lacking. According to their 
participants’ accounts, educational efforts aimed at increasing knowledge about AF and 
warfarin were minimal and insufficient.  
 
“Nobody really explained to me in full what Coumadin is all about, but I 
did some reading about it. I know it's a blood thinner, an anti-coagulant... 
helps with the atrial fibrillation that I have, because apparently blood stays 
longer than it should in the atrium, and if it thickens it can go to your brain 
and you can have a stroke.” (Patient 8) [21] 
 
This viewpoint is corroborated by health-care professionals in Bajorek et al [22] study 
who suggest that the educational information provided is often inadequate to the point 
that existing educational resources are not readily employed. Furthermore Lipman et 
al. [23] explored with General Practitioners (GPs) what educational information on 
OAC was discussed during consultations. More than half reported that they gave a 
limited amount of information about risks of warfarin to the patient.   
 
“... I don’t use risk tools, facts and figures it’s a... more of a generality of 
erm... ‘It’s just going to reduce your risk of stroke and it should prolong 
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your life’ and erm... ...you know maybe I shouldn’t but I don’t have... I don’t 
use NNTs [Number Needed to Treat]” (GP 10) [23] 
 
Indeed, GPs were found to have different communication styles with varying rates of 
success. Some GPs preferred discussing statistics about risks associated with warfarin 
to help the patient reach a decision about warfarin uptake, while others preferred to 
avoid probabilities and statistics and instead offered a more doctor-led style. [23] 
 
Patients commented that information during the consultation is often rushed. The 
following patient suggested that written information should be given, which could be 
further explained by the GP. 
 
“The cardiologist . . . says you should cut out certain food, vegetables, or 
reduce the quantities . . . I found it very difficult to sit on the other side of 
his desk and try and make notes of what he was saying. Now to him it is a 
regular thing, it is a routine thing . . . for me it is the first time I hear this. 
For 50 years I have been eating this or that . . . I don’t think it should be left 
verbally . . . (You) should be given a briefing sheet or something to take 
away . . . (then) see your GP and he follows this up with verbal advice.” 
(Patient) [22] 
 
A further complication is that diagnosis or treatment advice may be given in secondary 
care. This is not always the best context for patients to take in the information provided. 
[24] 
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“Education in the hospital ward…you are asking a lot when somebody is in 
a four bedded room…(pharmacist) trying to explain something to you…you 
can’t hear, you can’t sleep very well…probably not the best place for you 
to have all this stuff explained to you…only so much we can do, it’s just too 
hectic.” (Nurse) [24] 
 
3.2 Deciding on OAC therapy 
Following information provision at diagnosis is the decision-making process regarding 
OAC therapy. Again the literature reveals a mix of strategies. Three studies explored 
OAC therapy decision-making with patients [21, 22, 24], and in each patient’s reported 
that the decision was taken by the doctor and that they were happy with this approach.  
 
“I can recall that I had no objection. I said, "You are the experts, you are the 
doctors. If I get any help, I mostly will appreciate it.".... I don't think I would 
trust myself that much (to make the right decision).” (Patient 15) [21] 
 
However, other health professionals (nurses, hospital pharmacists) caution against this 
didactic consultation style, where a patient accepts a drug based on the trust they have 
in the expert [22, 24]. The argument was postulated that patients should be responsible 
for their health and voice their concerns, rather than abdicating responsibility for health 
care decisions to their doctor.  
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“A lot of the older patients – ‘my doctor says it is good for me so I’ll take 
it…they are an expert’…are pretty bad because they don’t ask questions.” 
(Nurse) [24] 
  
Some patients wanted sufficient information to make an informed decision but also 
required time to reflect on it before discussing it further with their GP. 
 
“I would personally prefer that I read the book first and then come back and 
say “I am not sure about this or that; could you explain this to me?” (Patient) 
[22] 
 
Dantas et al. [21] found that some patients had commenced OAC while hospitalised 
because of an emergency or another illness and therefore preventing an active informed 
decision. Under these circumstances patients often ended up being presented with 
warfarin as their only therapeutic option which is perceived as a problem by some [21, 
22, 24].  
 
When I went into the (clinic) to see my doctor, they admitted me to the 
cardiac emergency, and they kept me there all day... I was in for just about 
a week... and when I was discharged the doctors explained that they were 
putting me on to certain medications, and Coumadin was one of them. 
(Patient 10) [21] 
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“They just don’t voice a concern about taking it because they don’t see they 
have any other option…just part of the treatment that’s been 
prescribed…they have to put up with it.” (Nurse). [24] 
 
In contrast physicians perceived this decision-making process as more of a negotiation. 
[23, 25] All GPs and senior physicians in these studies argued that patients’ ideas, 
concerns and expectations about OAC therapy should be central to consultations but 
the conclusion was that there was “a range of views as to the extent to which physicians 
would allow patients to be the ‘final’ decision-maker”. [25] 
 
“I like to advise… identify what the patient thinks they need, what I think 
they should have, and then if it’s acceptable we come to an agreement and 
we try to take it forward, it’s negotiation, try more and more nowadays to 
do that in a consultation…” (GP1) [23] 
 
“I would almost put the decision or the ball in his court and I would go down 
the lines of describing to him his absolute and relative risk reductions with 
aspirin and warfarin… and I’d see what he’d prefer to do” (Physician) [25] 
 
However GPs feel responsible for the outcome (stroke or bleeding event) when a patient 
doesn’t take the “right” treatment decision. [23] This is more often the case with the 
‘family-doctor’ relationship built over time, than hospital physicians. [23] These 
feelings often prevent GPs from prescribing warfarin for fear of causing bleeds.  
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“Well it’s my fault for putting it in a way that . . . that perhaps didn’t put the 
benefits and harms quite in context. I’ve made a mistake in how I’ve 
described the risk for that individual patient because they made a decision 
which I think is probably the wrong decision . . .” (GP4)  [23] 
 
3.3 Challenges revolving around patient issues 
Researchers found that patients’ beliefs were influenced by their ‘experiential’ 
knowledge [26], that is knowledge gained through their experience. This knowledge 
often had a negative influence on warfarin acceptance. [21, 23, 27, 28]  A common 
patient belief mentioned in these six studies was the awareness of warfarin being used 
as rat poison.  
 
“‘Hang on doctor’ he said ‘That’s the stuff they use to poison rats with isn’t 
it’, I said ‘That’s . . . well it is and how do you . . . ’ and he said ‘Oh I was 
a rat catcher for the council, I don’t want that because I’ve seen too many 
things happen to rats with that’.” (GP1) [23] 
 
Similarly, older participants in Fuller et al’s [28] study saw friends or family members 
have haemorrhagic strokes, and associated the increased risk of bleeding from OAC 
therapy with a possible haemorrhagic stroke. This could easily be misconstrued as the 
same medication that is lowering the risk of an embolic stroke is increasing the risk of 
a haemorrhagic stroke.  
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“Bleeding into the brain – isn’t that fatal? Happened to someone I know” 
(Patient 72, aged 78) [28] 
 
Howitt & Armstrong [27] argued that patients who refused to take warfarin did not 
perceive themselves as vulnerable. Such patients believed that a stroke can only happen 
to people with an unhealthy lifestyle. This constitutes an avoidant coping mechanism, 
or denial, lived out in their agreement to take only aspirin.  
 
“People who have strokes are overweight, drink and smoke. I don't think it 
will happen.” (Patient 16, final treatment aspirin) [27] 
 
There are other issues related to lifestyle which resulted in refusal of, or a negative 
perception of, warfarin: the need for regular blood tests to monitor anticoagulation 
control, the amount of time it takes to do the tests, abstinence of alcohol, and an ever 
increasing amount of tablets. [19, 21, 23, 24, 28, 29] 
 
“I’ve had one patient who has refused to go on warfarin . . . because he 
doesn’t want to take it, he doesn’t want to have that commitment to taking 
medication, to being monitored you know to possibly having the side effects 
that he might have, even though he is aware of the potential benefits, now 
if that’s . . . if that’s his decision that’s fine by me, it’s not my life, I’m not 
taking warfarin for the rest of my life you know.” (GP11) [23] 
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Monitoring was reported as particularly disruptive when planning holidays or working. 
These patients were more likely to feel inconvenienced than those who were monitored 
less frequently. [29] Patients’ resistance to follow-ups was also reported as a challenge. 
[20] 
 
“I have to miss work to get my blood work done or go visit the doctor to get 
a prescription and depending on their hours, sometimes I have to leave.” 
(Patient US Group 6) [29] 
 
However, some patients viewed the regular bloods positively as the monitoring 
confirmed their warfarin control. [21, 29] 
 
“I like getting it checked. It makes me feel more comfortable, as far as know 
I’m okay.” (Patient US Group 11) [29] 
 
3.4 Healthcare challenges 
Communication between primary and secondary care was a key challenge identified in 
the synthesis. [20, 22, 23] The lack of communication between hospital physicians and 
GPs meant neither took responsibility for patient education, which in turn has 
significant consequences for patient adherence. [22, 23] 
 
“Decision making for who goes on warfarin is taken often by one person, 
monitoring of warfarin is taken by another person and in our practice people 
are monitored in 5 different systems, alright and er . . . ongoing 
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responsibility for patient education is nonexistent . . . the potential risks of 
warfarin to me are so large in terms of errors basically.” (GP2) [23] 
 
“It may create conflict with the patient too . . . especially if the other health 
professional said something (different)” (GP) [22] 
 
The common problem of limited personnel and time pressures on consultation time was 
identified by health professionals, nurses and GPs as a barrier to investment in patient 
education. [22, 24] 
 
“The doctors all roll up at 9 o’clock in the morning to do their rounds - ‘yep 
they can go home…there are five other people down in A&E waiting to 
come up, let’s ship them down to transit lounge.’ - they get home and open 
up this little plastic bag with all their drugs…pharmacist hasn’t had a chance 
to talk to them…we haven’t seen what they‘re on…pressure to get them 
out. .” (Nurse) [24] 
 
The nurse above and GP below suggested that since time is limited, responsibility to 
educate patients could be shifted to pharmacists, either at the hospital or in the 
community which may improve compliance. In addition, Bajorek et al [22] argued that 
such a strategy could aid patient surveillance and education. 
 
If they are in there looking at the patient in-house . . . then that is probably 
quite useful . . . I usually don’t have the time . . . If the pharmacist is actually 
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sitting down with them and looking at how they are managing their tablets 
at home . . . [monitoring] compliance [and] suggesting that the dosette is the 




4. Discussion and Conclusion 
This meta-synthesis has enabled us to consolidate the knowledge about patients’ and 
physicians’ understanding of AF, risk perception management in relation to OAC 
therapy and the settings in which AF is diagnosed and treatment discussed. The 
National Institute for Health and Clinical Excellence guidelines [1] prioritise patient-
led care which requires better rapport between physicians and patients.  
 
Shared decision-making is imperative for patient-led care. Wirtz et al [30] discussed 
four models of patient-doctor decision-making (see Figure 3). Patients’ experiences 
during the decision-making process synthesised here suggest a mixture of the 
paternalistic and interpretative models. While the physicians’ experiences clearly 
indicate that a shared decision making model is being used. This contradiction warrants 
further study but could be related to the patient’s trust in the expertise of the physician 
and may explain why patients submit to physicians’ decisions. Evidence suggests that 
the concept of trust between patients and physicians is vital for a successful relationship 
[31, 32], which in turn is crucial for treatment adherence. Trust, in this case, is manifest 
in a positive acceptance of the sick role and belief that physicians will care for their 
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interests [33]. In critical consultations, where potential risk and negative outcomes are 
discussed, what is interpreted as trust in the physician could also be due to the need to 
escape responsibility from a difficult decision.   
 
Participants, both patients and health professionals commented that lack of time was an 
issue within the health-care system both with regard to patient education and physician 
workload. Deveugeule et al [34] found that the mean length of consultations in the UK 
was almost 10 minutes. Similar to the findings of this synthesis, the literature suggests 
that this is not enough time to establish rapport with the patient, transmit information, 
and address the patient’s needs [35, 36], which could have an effect on patient 
adherence to treatment. Developments in health psychology have resulted in several 
theoretical models for understanding variations in adherence to treatment. [37]  
 
In explaining how beliefs might influence patients’ decisions on adherence with 
prescribed medications, Horne [38] proposed that although beliefs about medicines in 
general influence the patients’ initial orientation toward medicines, adherence 
behaviour is likely to be more strongly related to personal views about the specific 
prescribed medication. In particular, adherence decisions are influenced by a cost–
benefit assessment in which personal beliefs about the necessity of the medication for 
maintaining or improving health are balanced against concerns about the potential 
adverse effects of taking it. [38] This means that within studies which have examined 
OAC therapy, patients’ concerns, such as the knowledge of OAC side effects and the 
need for lifestyle change, outweigh the necessity of the medication in the reduction of 
thrombo-embolism. This may be due to the fact that OAC therapy is not a 100% fail-
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safe treatment and one can still encounter a stroke even though the risk is much lower. 
Therefore patients should be regarded as active decision makers who will be more 
motivated to use their medication if imparting of information targets the necessity of 
OAC outweighing their concerns about taking it. However further research on the lived 
experiences of physicians and patients is required to corroborate this. Such research 
could have an impact on practice, by encouraging health professionals to understand 
and attend better to the needs and concerns of the patient. 
 
The benefit of incorporating qualitative evidence like that presented in this meta-
synthesis within the larger hierarchy of evidence is that it can add depth; it can bring 
the focus back to the individual to ensure that population-based findings retain their 
applicability to the individual case. [39] The model of mixed evidence enables a holistic 
approach to evidence-based health care that contextualizes the biomedical data by also 
making sense of the social determinants of health which are critical when designing 
interventions for individuals leading complex lives. [40] 
 
This meta-synthesis clearly identifies the key challenges facing AF patients and 
healthcare professionals who manage their treatment, namely the importance of an early 
and accurate diagnosis, necessity of sufficient education pertaining to AF and available 
treatment, particularly OAC, and identification of patient barriers to treatment to 
improve adherence. This qualitative meta-synthesis highlights that central to all these 
issues is the effective communication of information in a variety of formats by different 
healthcare professionals, and the need for an individualised approach based on 
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discussions with patients regarding their preferences for decision-making and treatment 





I confirm all patient/personal identifiers have been removed or disguised so the 
patient/person(s) described are not identifiable and cannot be identified through 
the details of the story.  
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